share_log

Obesity In Children - US Parents Face Tough Time To Access Recommended Treatment, Though Novo Nordisk's Drug Still Sees Strong Demand

Obesity In Children - US Parents Face Tough Time To Access Recommended Treatment, Though Novo Nordisk's Drug Still Sees Strong Demand

兒童肥胖症-美國家長很難獲得推薦的治療,儘管諾和諾德的藥物仍然有強烈的需求
Benzinga ·  06/18 12:30

Many U.S. parents seeking help for their child with obesity face challenges accessing the recommended treatment. Leading medical groups advocate for intensive behavioral counseling, requiring 26 hours within a year to teach healthier eating and activity habits.

許多爲肥胖子女尋求幫助的美國父母在獲得推薦治療方面面臨挑戰。領先的醫療團體主張強化行爲諮詢,一年內需要26個小時來教導更健康的飲食和活動習慣。

Also Read: Novo Nordisk Sues Additional US Clinics Against Fake Semaglutide Products Used For Weight Loss, Diabetes.

另請閱讀: 諾和諾德針對用於減肥、糖尿病的假冒索瑪魯肽產品起訴其他美國診所。

However, as numerous doctors and parents have noted, these programs are often unavailable, have long waitlists, are not covered by insurance, and require significant time commitments.

但是,正如許多醫生和家長所指出的那樣,這些計劃通常不可用,等待名單很長,不在保險範圍內,並且需要大量的時間投入。

The U.S. Centers for Disease Control and Prevention (CDC) revealed that fewer than 1% of the nearly 15 million children with obesity receive such structured care, Reuters reported.

路透社報道,美國疾病控制與預防中心(CDC)透露,在近1500萬肥胖兒童中,只有不到1%的人接受了這種結構化護理。

Efforts to expand insurance coverage have stalled. "The coverage for these programs was never good, and we're not seeing any movement toward improvement," said Dr. Joseph Skelton, a professor of pediatrics at Wake Forest University School of Medicine.

擴大保險覆蓋範圍的努力停滯不前。維克森林大學醫學院兒科教授約瑟夫·斯凱爾頓博士說:“這些項目的覆蓋範圍從來都不是很好,我們也沒有看到任何改善的進展。”

Obesity rates among U.S. children have climbed from 5% in 1980 to nearly 20% today, the report noted, citing CDC data.

報告援引疾病預防控制中心的數據指出,美國兒童的肥胖率已從1980年的5%攀升至今天的近20%。

While Novo Nordisk A/S's (NYSE:NVO) Wegovy offers an effective weight-loss solution for adults and adolescents, there is concern about its long-term effects on children's development.

儘管諾和諾德A/S(紐約證券交易所代碼:NVO)Wegovy爲成人和青少年提供有效的減肥解決方案,但人們擔心其對兒童發育的長期影響。

Despite these concerns, demand for Wegovy remains high, with at least 25,000 first-time prescriptions dispensed weekly to adults.

儘管有這些擔憂,但對Wegovy的需求仍然很高,每週至少向成年人發放25,000張首次處方。

Changing habits instead of medication is the preferred approach for some families. The report cited Medina's 15-year-old daughter, Jelainie, who enrolled in a healthy weight program at Holyoke Health Center. However, the program has a four-month waitlist, and state Medicaid partially covers participation.

對於某些家庭來說,改變習慣而不是藥物治療是首選的方法。該報告援引了麥地那15歲的女兒傑萊妮的話,她參加了霍利奧克健康中心的一項健康體重計劃。但是,該計劃有四個月的候補名單,州醫療補助計劃部分涵蓋參與費用。

At Stanford Medicine Children's Health, Dr. Thomas Robinson emphasized that reliance solely on drugs could lead to nutritional deficiencies or eating disorders.

在斯坦福醫學院兒童健康中心,托馬斯·羅賓遜博士強調,僅僅依賴藥物可能導致營養不足或飲食失調。

The report further noted that Stanford's program teaches families to categorize foods into "red-light" (to be eaten sparingly), "yellow-light," and "green-light" (to be consumed freely) foods, though it costs $3,500 and is not covered by insurance.

該報告進一步指出,斯坦福大學的計劃教導家庭將食物分爲 “紅燈”(少量食用)、“黃光” 和 “綠光”(可自由食用)食物,儘管費用爲3500美元,而且不在保險範圍內。

Efforts to improve insurance coverage for obesity counseling face hurdles. The American Medical Association (AMA) recently rejected a request for a dedicated medical code for the 26-hour counseling program, which would help providers bill for services, per the report.

改善肥胖諮詢保險覆蓋範圍的努力面臨障礙。報告稱,美國醫學協會(AMA)最近拒絕了爲26小時諮詢計劃提供專門醫療守則的請求,該法規將幫助提供者開具服務賬單。

The CDC stressed the need for equitable access to both obesity medications and lifestyle treatments to support children's health.

疾病預防控制中心強調,需要公平獲得肥胖藥物和生活方式治療,以支持兒童的健康。

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

免責聲明: 該內容部分是在人工智能工具的幫助下製作的,並由Benzinga編輯審閱和發佈。

Photo via Shutterstock

照片來自 Shutterstock

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論